Minapharm Pharmaceuticals (CAI:MIPH) EV-to-Revenue : (As of Jun. 15, 2024)

View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Minapharm Pharmaceuticals's enterprise value is E£4,221 Mil. Minapharm Pharmaceuticals does not have enough years/quarters to calculate its Revenue for the trailing twelve months (TTM) ended in Dec. 2022. Therefore, GuruFocus does not calculate Minapharm Pharmaceuticals's EV-to-Revenue at this moment.

The historical rank and industry rank for Minapharm Pharmaceuticals's EV-to-Revenue or its related term are showing as below:

CAI:MIPH' s EV-to-Revenue Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0
Current: 1.08

CAI:MIPH's EV-to-Revenue is ranked better than
76.13% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 2.24 vs CAI:MIPH: 1.08

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-15), Minapharm Pharmaceuticals's stock price is E£191.98. Minapharm Pharmaceuticals does not have enough years/quarters to calculate its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2022. Therefore, GuruFocus does not calculate Minapharm Pharmaceuticals's PS Ratio at this moment.

Minapharm Pharmaceuticals EV-to-Revenue Historical Data

The historical data trend for Minapharm Pharmaceuticals's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals EV-to-Revenue Chart

Minapharm Pharmaceuticals Annual Data

Trend

Dec22

Dec23

EV-to-Revenue

0.73

1.19

Minapharm Pharmaceuticals Quarterly Data
	Dec22	Dec23
EV-to-Revenue	-	-

Competitive Comparison of Minapharm Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Minapharm Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Minapharm Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Minapharm Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Minapharm Pharmaceuticals's EV-to-Revenue falls into.

Minapharm Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Minapharm Pharmaceuticals's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	4220.879	/
	=

Minapharm Pharmaceuticals (CAI:MIPH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Minapharm Pharmaceuticals's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	191.98	/
	=

Minapharm Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Minapharm Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Minapharm Pharmaceuticals (CAI:MIPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY

Website

http://www.minapharm.com

Minapharm Pharmaceuticals produces prescription drugs in Egypt and the Middle East. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals (CAI:MIPH) Headlines

No Headlines